(Q42550309)
Statements
1 reference
Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer. The Epirubicin High Dose (HEPI 010) Study Group (English)
1 reference
G Brufman
1 reference
E Colajori
1 reference
N Ghilezan
1 reference
M Lassus
1 reference
A Martoni
1 reference
N Perevodchikova
1 reference
C Tosello
1 reference
D Viaro
1 reference
C Zielinski
1 reference
1 February 1997
1 reference
1 reference
8
1 reference
2
1 reference
155-162
1 reference
Identifiers
1 reference
1 reference